Russell Wall

475 total citations
6 papers, 239 citations indexed

About

Russell Wall is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Russell Wall has authored 6 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Russell Wall's work include Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (3 papers) and HER2/EGFR in Cancer Research (2 papers). Russell Wall is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (3 papers) and HER2/EGFR in Cancer Research (2 papers). Russell Wall collaborates with scholars based in United States and Canada. Russell Wall's co-authors include Mark D. Minden, Christian Barrett, Kelly A. Frazer, Angela C. Court, Maurizio Pellecchia, M Zipeto, Marco A. Marra, Qingfei Jiang, Anil Sadarangani and Larisa Balaian and has published in prestigious journals such as Blood, Cancer Research and Cell stem cell.

In The Last Decade

Russell Wall

6 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Russell Wall United States	3	187	67	43	40	38	6	239
Maria Trissal United States	9	186 1.0×	130 1.9×	48 1.1×	13 0.3×	40 1.1×	17	258
Bofei Wang United States	8	89 0.5×	43 0.6×	21 0.5×	32 0.8×	38 1.0×	24	151
Wenlan Yang China	7	274 1.5×	163 2.4×	25 0.6×	24 0.6×	53 1.4×	9	367
Karina Vázquez-Arreguín United States	6	88 0.5×	35 0.5×	58 1.3×	20 0.5×	19 0.5×	10	180
Liwen Yang Germany	7	101 0.5×	72 1.1×	89 2.1×	12 0.3×	35 0.9×	17	193
Carolina Pola United States	3	240 1.3×	81 1.2×	50 1.2×	5 0.1×	24 0.6×	7	287
Jean Pascal Machiels United States	3	105 0.6×	43 0.6×	114 2.7×	67 1.7×	146 3.8×	3	262
Benjamin Tanenbaum United States	5	130 0.7×	55 0.8×	48 1.1×	10 0.3×	16 0.4×	6	191
Laura Wiehle Germany	5	240 1.3×	23 0.3×	38 0.9×	26 0.7×	19 0.5×	7	279
Catherine A. Eberlein United Kingdom	4	69 0.4×	37 0.6×	74 1.7×	15 0.4×	27 0.7×	4	149

Countries citing papers authored by Russell Wall

Since Specialization

Citations

This map shows the geographic impact of Russell Wall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Wall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Wall more than expected).

Fields of papers citing papers by Russell Wall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell Wall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Wall. The network helps show where Russell Wall may publish in the future.

Co-authorship network of co-authors of Russell Wall

This figure shows the co-authorship network connecting the top 25 collaborators of Russell Wall. A scholar is included among the top collaborators of Russell Wall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell Wall. Russell Wall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Degenhardt, Jeremiah D., Pui Seto, Jessica Krakow, et al.. (2022). Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186. Journal for ImmunoTherapy of Cancer. 10(6). e004336–e004336. 10 indexed citations

2.

Seto, Pui, Russell Wall, Brian J. Hillier, et al.. (2020). COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors. mAbs. 12(1). 1792130–1792130. 41 indexed citations

3.

Degenhardt, Jeremiah D., Maia Vinogradova, Pui Seto, et al.. (2019). Abstract 557: COBRA: A novel conditionally active bispecific antibody that regresses established solid tumors in mice. Cancer Research. 79(13_Supplement). 557–557. 2 indexed citations

4.

Zipeto, M, Angela C. Court, Anil Sadarangani, et al.. (2016). ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis. Cell stem cell. 19(2). 177–191. 183 indexed citations

5.

Court, Angela C., Anil Sadarangani, Daniel Goff, et al.. (2011). Combination Targeted Therapy to Impair Self-Renewal Capacity of Human Blast Crisis Leukemia Stem Cells. Blood. 118(21). 1693–1693. 2 indexed citations

6.

Goff, Daniel, Alice Shih, Angela C. Court, et al.. (2010). The Pan-Bcl-2 Family Inhibitor 97C1 Targets Blast Crisis Chronic Myeloid Leukemia Stem Cells but Spares Normal Cord Blood Progenitor Cells. Blood. 116(21). 516–516. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact